Consilium Wealth Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Consilium Wealth Advisory's LLY Position: Q1 2026 in Review
Consilium Wealth Advisory increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $367K and bringing the position to 3,722 shares worth $3.42M. The position accounts for 1.17% of the portfolio, ranked #22.
Consilium Wealth Advisory first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.1M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Consilium Wealth Advisory held 3,722 shares of Eli Lilly worth $3.42M as of Q1 2026.
- Consilium Wealth Advisory bought 362 Eli Lilly shares in Q1 2026, an estimated $367K.
- Eli Lilly made up 1.17% of Consilium Wealth Advisory's portfolio in Q1 2026, its #22 holding.
- Consilium Wealth Advisory first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Consilium Wealth Advisory's Eli Lilly position peaked at $4.1M in Q2 2024.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Consilium Wealth Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.